Rabourn Amy Zaremba Ocuphire Pharma, Inc. (OCUP) insider trading activity

Rabourn Amy Zaremba is Head of Fin. Quality Assurance of Ocuphire Pharma, Inc.. Currently has a direct ownership of 193,128 shares of OCUP, which is worth approximately $189,265. The most recent transaction as insider was on Jan 22, 2026, when has been sold 86,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 193K

69.46% 3M change

133.65% 12M change

Total Value Held $189,265

Rabourn Amy Zaremba Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 22 2026	BUY Grant, award, or other acquisition	-	86,500 Added 30.93%	193,128 Common Stock
Jan 18 2026	SELL Payment of exercise price or tax liability	$7,119 $2.1 p/Share	3,390 Reduced 3.08%	106,628 Common Stock
Jan 10 2026	SELL Payment of exercise price or tax liability	$7,623 $1.93 p/Share	3,950 Reduced 3.47%	110,018 Common Stock
Mar 13 2025	BUY Grant, award, or other acquisition	-	39,500 Added 25.74%	113,968 Common Stock
Feb 04 2025	SELL Payment of exercise price or tax liability	$9,336 $1.14 p/Share	8,190 Reduced 9.91%	74,468 Common Stock
Jan 18 2024	BUY Grant, award, or other acquisition	-	40,000 Added 32.61%	82,658 Common Stock
Jan 10 2024	SELL Payment of exercise price or tax liability	$12,916 $3.27 p/Share	3,950 Reduced 8.47%	42,658 Common Stock

Jan 10 2023	BUY Grant, award, or other acquisition	-	46,608 Added 50.0%	46,608 Common Stock

RAZ

Rabourn Amy Zaremba

Head of Fin. Quality Assurance

Farmington Hills, MI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUP shares.

Notify only if

Value

Insider Trading

Get notified when an Ocuphire Pharma, Inc. insider buys or sells OCUP shares.

Notify only if

Operation

Value

Type

News

Receive news related to Ocuphire Pharma, Inc.

Track Activities on OCUP

Account